Evolent Health, Inc.
NYSE:EVH
10.25 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -113.04 | -19.164 | -37.601 | -334.246 | -305.58 | -54.191 | -69.767 | -226.778 | 319.814 | -25.246 | 20.023 | -19.263 |
| Depreciation & Amortization
| 123.415 | 67.195 | 60.037 | 61.475 | 60.913 | 44.515 | 32.368 | 17.224 | 7.166 | 0 | 1.208 | 0.114 |
| Deferred Income Tax
| -31.272 | 0.342 | -0.526 | -1.132 | -23.124 | 0.044 | -7.271 | -10.755 | 23.46 | 0 | 4.241 | 0 |
| Stock Based Compensation
| 40.501 | 33.981 | 16.711 | 14.606 | 15.618 | 17.609 | 20.437 | 22.501 | 14.73 | 0 | 0.091 | 0.087 |
| Change In Working Capital
| 21.892 | -104.441 | -13.645 | -55.319 | 0.331 | -34.866 | -7.284 | -4.429 | 2.158 | -49.896 | 6.227 | -1.792 |
| Accounts Receivables
| -164.694 | -102.98 | -5.779 | -47.017 | 6.326 | -24.503 | -11.258 | -11.044 | 11.756 | 0 | -8.67 | -1.792 |
| Inventory
| -10.746 | 0 | -14.116 | 47.017 | -19.503 | 0.644 | -1.834 | 5.108 | -5.766 | 0 | 2.919 | 0 |
| Accounts Payables
| -6.723 | 13.165 | 7.25 | 3.547 | -5.48 | 7.598 | 5.563 | -6.371 | 2.764 | 0 | -0.843 | 0 |
| Other Working Capital
| 204.055 | -14.626 | -1 | -58.866 | 18.988 | -18.605 | 0.245 | 7.878 | -6.596 | -49.896 | 12.821 | 0 |
| Other Non Cash Items
| 101.086 | 10.534 | 13.771 | 298.391 | 209.197 | 6.238 | 3.559 | 166.727 | -387.157 | 75.142 | -45.419 | 6.382 |
| Operating Cash Flow
| 142.582 | -11.553 | 38.747 | -16.225 | -42.645 | -20.651 | -27.958 | -35.51 | -19.829 | -75.094 | -13.629 | -12.767 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -28.745 | -38.361 | -24.983 | -29.473 | -35.534 | -39.55 | -27.848 | -15.526 | -6.515 | -11.034 | -10.438 | -2.329 |
| Acquisitions Net
| 0 | 5.552 | -34.794 | -0.3 | -96.055 | -139.601 | -4.822 | -85.56 | 13.065 | 0 | -15.521 | 0 |
| Purchases Of Investments
| 0 | -5.552 | -2.995 | -11.17 | -11.125 | -10.01 | -3.805 | -9.09 | -54.234 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 5.552 | 0.5 | 143.441 | 2.575 | 0.349 | 44.21 | 9.379 | 4 | 0 | 0 | 0 |
| Other Investing Activites
| -386.799 | -226.306 | 46.486 | 158.574 | -41.495 | 28.437 | -20 | -6.09 | -50.234 | 7.458 | 0.05 | -1.45 |
| Investing Cash Flow
| -415.544 | -259.115 | -15.786 | 261.072 | -181.634 | -160.375 | -12.265 | -97.797 | -43.684 | -3.576 | -25.909 | -3.779 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 183.293 | 160.291 | -37.687 | 13.456 | 62.648 | 167.178 | 0 | 121.25 | 0 | 0 | 23 | 0 |
| Common Stock Issued
| 0 | 4.452 | 13.289 | 2.577 | 1.092 | 11.929 | 166.947 | 177.795 | 209.087 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -18.318 | -3.85 | -1.851 | -2.609 | -1.236 | 0 | -0.365 | 0 | 0 | -0.1 | 0 |
| Dividends Paid
| -18.793 | -14.884 | -1.3 | -20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 104.321 | -18.318 | 9.439 | -3.467 | -95.584 | 106.846 | -1.39 | -0.365 | -1.209 | -1.365 | 11.286 | 0 |
| Financing Cash Flow
| 281.34 | 131.541 | -29.548 | -11.862 | -35.545 | 274.024 | 165.557 | 122.144 | 209.239 | -1.365 | 34.286 | 4.5 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.079 | -0.657 | -0.052 | 0.065 | 0.03 | -0.036 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 8.299 | -139.784 | -6.639 | 233.05 | -259.794 | 92.962 | 125.334 | -11.163 | 145.726 | -80.035 | -5.252 | -12.046 |
| Cash At End Of Period
| 223.457 | 215.158 | 354.942 | 361.581 | 128.531 | 388.325 | 295.363 | 134.563 | 145.726 | -80.035 | 0 | 5.252 |